TAO Synergies Inc.
TAOXNASDAQTechnologySoftware - Application
Regular session
$3.9844
+$0.1244 · +3.22%
TAOX company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
46
Fair Value
Momentum
18
Strong Down
Sentiment
56
Mixed
Risk resilience
25
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteTAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
- Industry
- Software - Application
- Sector
- Technology
- Headquarters
- US
- CEO
- Joshua N. Silverman
- Listed since
- Jul 2, 2025
- Employees
- 5
Market position
Day range
Current $3.9844
52-week range
Current $3.9844
- Open
- $3.92
- Previous close
- $3.86
- Volume
- 107.37K
- 0.89× average
- Average volume
- 120.23K
- Average daily volume
- Market cap
- 29.77M USD
- Beta
- 1.47
- Market reference 1
- 50-day average
- $3.588
- +11.05% above average
- 200-day average
- $4.8057
- -17.09% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 6.65M USD
- P/E (TTM)
- -1×
- P/B (TTM)
- 1.72×
- P/S (TTM)
- 38.54×
- EV / EBITDA
- -0.74×
- Earnings yield
- -236.62%
- Free cash flow yield
- -52.66%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 99.90%
- Operating margin
- -1085.25%
- Net margin
- -2155.49%
- Return on equity
- -131.23%
- Return on assets
- -111.23%
- Return on invested capital
- -37.66%
Financial health
- Debt / equity
- 0×
- Current ratio
- 13.99×
Financial statements
Income trends
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 299.06K USD | — | — | — | — |
| Gross profit | 299.06K USD | — | — | — | — |
| Research and development | 322.23K USD | 1.6M USD | 1.97M USD | 6.32M USD | 4.34M USD |
| Selling, general, and administrative | 9.02M USD | 5.21M USD | 6.34M USD | 9.81M USD | 8.28M USD |
| Operating expenses | 9.35M USD | 6.81M USD | 8.31M USD | 16.13M USD | 12.62M USD |
| Interest income | 442.91K USD | 1.28M USD | 1.65M USD | 335.04K USD | 7.11K USD |
| Depreciation and amortization | 3.62K USD | 5.58K USD | 6.35K USD | 5.71K USD | 4.97K USD |
| Operating income | −9.05M USD | −6.81M USD | −8.31M USD | −16.13M USD | −12.62M USD |
| Net income | −28.74M USD | −12.77M USD | −6.04M USD | −5.57M USD | −12.61M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 67%
- 4 beats, 2 misses, 0 met estimates
- Average EPS surprise
- +11.94%
- 6 comparable reports
- Latest EPS result
- -1.83
- Estimate -12.75 · Beat by 85.65%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
TAOX news
TAOX peers
ETFs holding TAOX
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Extended Market ETFVXF- Market value
- 260.24K
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $243.79-0.71%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 176.65K
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $377.57-0.18%
iShares Micro-Cap ETFIWC- Market value
- 95.92K
- Weight
- 0.01%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $197.12-0.51%
U.S. Micro Cap Portfolio ETFDFMC- Market value
- 2.94K
- Weight
- 0.00%
- AUM
- 8.06B USD
- Expense ratio
- 0.43%
- Price / 1D
- $60.795-0.30%
Continue in GoAI
Research TAOXresearch.disclaimer